Fri.Feb 21, 2025

article thumbnail

The Data For Weight Loss Medications Just Keeps Pouring In.

Dr. Paddy Barrett

“There are decades where nothing happens; and there are weeks where decades happen.” Vladimir Ilyich Lenin. It always feels strange to quote Lenin, but when it comes to weight loss medications, it is hard not to feel that decades are happening right before our eyes. For over 50 years, rates of those who are overweight or obese have been rising rapidly.

Obesity 77
article thumbnail

The Coming ATTR-CM Competition

CardiacWire

Competition breeds innovation, and thats good news for ATTR-CM patients who could have three different drugs to choose from: Vyndaqel (Pfizer), Attruby/Beyonttra (BridgeBio), and Amvuttra (Alnylam). ATTR-CM affects more than 120k Americans with 5-7k new cases each year, but underdiagnosis means there could be even more. The disease occurs when misfolded proteins build up in the heart and stiffen the heart muscle, leading to heart failure.

article thumbnail

Persistence of a Proteomic Signature After a Hypertensive Disorder of Pregnancy

Hypertension Journal

Hypertension, Ahead of Print. BACKGROUND:A hypertensive disorder of pregnancy is associated with a higher risk of cardiovascular disease later in life, but the potential mechanistic links are unknown.METHODS:We recruited 2 groups of women, 1 during pregnancy and another at least 2 years after delivery. Cases had a hypertensive disorder of pregnancy, and controls had a normotensive pregnancy.

article thumbnail

Ozempic, Wegovy Shortage Is Officially Over

Med Page Today

(MedPage Today) -- The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current and projected U.S. demand.

116
116
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Language barriers in health care: Patient-doctor common tongue key to decreasing cardiovascular disease and longer life

Medical Xpress - Cardiology

A positive patient-doctor relationship is an ingredient to a healthy life, and new research has zeroed in on the impact common language in the relationship can have by decreasing cardiovascular disease for the benefit of a longer life.

article thumbnail

New Biosimilar, Ustekinumab-aekn, Now Available in U.S.

HCPLive

Alvotech and Teva announced that the biosimilar will be interchangeable with the reference after ustekinumab-auubs exclusivity expires in April 2025.

96

More Trending

article thumbnail

Omalizumab Linked to Greatest Rate of Hypersensitivity Reactions in Atopic Diseases

HCPLive

A study analyzed hypersensitivity reactions to biologics for atopic diseases, highlighting reaction types, severity, and biologic discontinuation rates.

78
article thumbnail

Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature

Journal of Cardiothoracic Surgery

Pericardial effusion is a relatively common complication associated with inflammatory and non-inflammatory diseases. The primary etiology of this condition could be considered when choosing therapeutic options.

59
article thumbnail

FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy)

HCPLive

The US supply of semaglutide and semaglutide 2.4 mg now meets or exceeds current and projected demand, ending the long-running shortages of these blockbuster drugs.

64
article thumbnail

Sacubitril/Valsartan partially alleviates myocardial infarction injury by activating the FGF21 signaling pathway via PPARs

Cardiovascular Diabetology

The recent discovery of clinically significant data, alongside novel physiological and pathological occurrences surrounding sacubitril/valsartan (Sac/Val) beyond its approved indications, necessitates an urgen.

article thumbnail

Oral Immunotherapy for Peanut Allergies Improves Quality of Life Post-Treatment

HCPLive

A meta-analysis found oral immunotherapy improves health-related quality of life post-food allergy treatment, but benefits during treatment remain unclear.

article thumbnail

Dangerous blood clot sidelines NBA star Victor Wembanyama for the season

Medical Xpress - Cardiology

One of the NBA's most exciting rising stars will spend the rest of the 20242025 season on the bench.

article thumbnail

Patch Test Highlights Allergens Impacting Alopecia Areata, Other Hair Conditions

HCPLive

Investigators in China developed a patch test designed for hair care products tailored to clinical needs such as those of patients with conditions like alopecia areata.

59
article thumbnail

Comparing Incidence of CV Events in Patients With T1D vs. T2D

American College of Cardiology

Patients with type 1 diabetes (T1D) were less likely to experience cardiovascular events when compared to patients with type 2 diabetes (T2D), according to a recent study published in the Journal of the Society for Cardiovascular Angiography & Interventions.

article thumbnail

FDA Approves Chenodiol Tablets for Cerebrotendinous Xanthomatosis

HCPLive

With this FDA approval, chenodiol tablets become the first approved drug to treat CTX, a rare lipid storage disease.

59
article thumbnail

Response by Bhimaraj et al to Letter Regarding Article, “Pitfalls in the World of Evidence-Based Medicine: Should IABP Be en-DANGER-ed by the DanGer Shock Trial?”

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print.

article thumbnail

New Biliary Atresia Guidance Released by American Academy of Pediatrics

HCPLive

The strategy detailed in the guidance aids the early identification of infants with biliary atresia and is intended for use between 2 and 4 weeks of life.

article thumbnail

Letter by Dalzell and Cannon Regarding Article, “Pitfalls in the World of Evidence-Based Medicine: Should IABP Be en-DANGER-ed by the DanGer Shock Trial?”

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print.

Article 40
article thumbnail

Vaccination and Pulmonary Rehabilitation in COPD

HCPLive

Panelists discuss how key nonpharmacological interventions include vaccinations to prevent infections, pulmonary rehabilitation to improve function, and lung cancer screening for high-risk patients to enable early detection.

article thumbnail

Disseminated Intracardiac Thrombosis Due to Long-Standing, Asymptomatic Ventricular Fibrillation Under Left Ventricular Assist Device Support

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print.

article thumbnail

Future Outlook in COPD

HCPLive

Panelists discuss how chronic obstructive pulmonary disease (COPD) management is evolving with personalized therapies, nonpharmacological care, and advanced treatments. Early diagnosis, adherence, and innovation offer hope for improved outcomes and quality of life.

article thumbnail

Effects of year Long Aerobic Exercise on Left Atrial Size in Patients with Left Ventricular Hypertrophy

The American Journal of Cardiology

Publication date: Available online 20 February 2025 Source: The American Journal of Cardiology Author(s): Douglas Kyrouac, Nicholas Talbot, James MacNamara, Erin Howden, Michinari Hieda, Christopher Hearon, Tiffany Brazile, Benjamin Levine, Satyam Sarma

article thumbnail

Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD

HCPLive

Furie discussed topline data from the REGENCY trial and key secondary endpoints.

49
article thumbnail

Adequacy of Loop Diuretic Dosing in Treatment of Acute Heart Failure: Insights from the BAN-ADHF Diuretic Resistance Risk Score

The American Journal of Cardiology

Publication date: Available online 20 February 2025 Source: The American Journal of Cardiology Author(s): Joseph Mauch, Max Puthenpura, Pieter Martens, Timothy Engelman, Justin L Grodin, Matthew W. Segar, Ambarish Pandey, W.H.

article thumbnail

Dose Modulation Results Compared in Risankizumab, Guselkumab for Psoriasis

HCPLive

These data suggest therapeutic modulation of IL-23 inhibitors for psoriasis in those who have shown stability may be a legitimate strategy to ensure efficacy and safety.

40
article thumbnail

Real-World Reductions in Lead-Free Radiation Exposure with the Rampart System during Endovascular Procedures

The American Journal of Cardiology

Publication date: Available online 20 February 2025 Source: The American Journal of Cardiology Author(s): Matthew S. Herzig, Ajar Kochar, James B. Hermiller, Rhian E. Davies, William J. Nicholson, Hibiki Orui, Eric. A.

40
article thumbnail

Physiology Friday #258: How Strength and Endurance Training Shape the Heart Differently in Men vs. Women

Physiologically Speaking

Greetings! Welcome to the Physiology Friday newsletter. If you’re looking for a new (mess-free) way to fuel your workouts, you should check out Intra Chew—it’s a workout gummy that has carbohydrates and electrolytes. I’ve been using them during all of my long bike rides and before runs. You can get 20% off using the code BRADY20 on the site.

article thumbnail

The Relationship Between Syncope and Cardiac Index in Acute Pulmonary Embolism

The American Journal of Cardiology

Publication date: Available online 21 February 2025 Source: The American Journal of Cardiology Author(s): Peter Zhang, Robert S. Zhang, Eugene Yuriditsky, Kevin Chen, Vincent Li, Lindsay Elbaum, Norma Keller, Allison A. Greco, Vikramjit Mukherjee, Radu Postelnicu, Kerry Hena, James M. Horowitz, Carlos L.

article thumbnail

ECG Blog #470 — This ECG Tells a Story

Ken Grauer, MD

The ECG in Figure-1 was obtained from a previously healthy middle-aged man who presented to the ED ( E mergency D epartment ) with new-onset CP ( C hest P ain ) that began ~1 hour earlier. QUESTION: The title I chose for todays Blog post is, This ECG tells a story. What is the Story that this initial ECG tells? Figure-1: The initial ECG in today's case obtained from a middle-aged man with CP. ( To improve visualization I've digitized the original ECG using PMcardio ).

Blog 118
article thumbnail

Shifting Perceptions of Hyperkalemia in Care of Patients with Heart Failure

CardiacWire

By Ravi Dhingra, MD, MPH, FACC, FAHA Sponsored By AstraZeneca Despite improving outcomes in patients with heart failure [1] , renin-angiotensin-aldosterone system inhibitor (RAASi) therapy is underutilized due to hyperkalemia (HK), often to the detriment of patients. [2] Ravi Dhingra, MD, MPH, FACC, FAHA An observational study [2] utilizing Optums de-identified Market Clarity Data from July 2019 to September 2021, evaluated the risk of progression to end-stage kidney disease (ESKD) and HF-relate

article thumbnail

Pruritus Linked to Depression, Sleep Interference in PBC, Negatively Impacting HRQoL

HCPLive

Patients with PBC and severe pruritus had worse HRQoL, greater rates of depression, and more sleep interference than those with mild/moderate pruritus.

59
article thumbnail

Left Bundle Branch Block LBBB and STEMI Criteria

All About Cardiovascular System and Disorders

Left Bundle Branch Block LBBB and STEMI Criteria: Start off with Cabrera’s sign and Chapmans sign. The post Left Bundle Branch Block LBBB and STEMI Criteria appeared first on All About Cardiovascular System and Disorders.

STEMI 52
article thumbnail

Catheter Ablation Improves Ventilatory Efficiency in Atrial Fibrillation‐Mediated Cardiomyopathy

Journal of Cardiovascular Electrophysiology

ABSTRACT Background Exercise Oscillatory Ventilation (EOV) and a steep ventilatory efficiency (VE/VCO2) slope are features of ventilatory inefficiency on cardiopulmonary exercise testing (CPET), both associated with poor prognosis in patients with heart failure (HF). The prevalence in patients with co-existent atrial fibrillation (AF) and the impact of catheter ablation (CA) is unknown.